Literature DB >> 16878020

Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock.

Shiro Ueda1, Kenji Nishio, Yasuhiro Akai, Hidetada Fukushima, Toru Ueyama, Yasuyuki Kawai, Kazuhiro Masui, Akira Yoshioka, Kazuo Okuchi.   

Abstract

Our objective was to investigate the plasma levels of brain and atrial natriuretic peptides (BNP and ANP, respectively) in patients with septic shock/severe sepsis and to study the association of BNP and ANP levels with hemodynamic parameters, severity of the disease, and prognosis of those patients. This is a prospective case series study of 22 patients with septic shock, 11 patients with severe sepsis, and 20 healthy volunteers at the Department of Emergency and Critical Care Medicine, Nara Medical University Hospital, Japan. Blood collection was performed on admission and on days 1, 2, and 4. Plasma BNP and ANP levels were measured by radioimmunoassay. Right atrial pressure, mean pulmonary arterial pressure, pulmonary arterial wedge pressure, and left ventricular stroke work index were determined using a thermodilution catheter. Acute Physiological and Chronic Health Evaluation II scores were calculated. Plasma levels of BNP and ANP were markedly elevated in patients with septic shock/severe sepsis compared with controls (BNP, 7 +/- 0.3 pg mL; ANP, 13 +/- 1 pg mL). In patients with septic shock, both BNP and ANP peaked on day 2 (BNP, 987 +/- 160 pg mL; ANP, 103 +/- 17 pg mL). Plasma levels of BNP on day 2 in patients with septic shock significantly correlated with right atrial pressure (r = 0.744, P < 0.01), mean pulmonary arterial pressure (r = 0.670, P < 0.01), pulmonary arterial wedge pressure (r = 0.709, P < 0.01), left ventricular stroke work index (r = -0.552, P < 0.05), Acute Physiological and Chronic Health Evaluation II score (r = 0.581, P < 0.01), and poor prognosis (P < 0.05). The optimal cutoff point for predicting mortality in patients with septic shock was a BNP level of 650 pg mL on day 2, in which sensitivity and specificity were 92% and 80%, respectively. Increased plasma levels of BNP may reflect not only the severity of myocardial depression but also the disease severity and could be of prognostic value in patients with septic shock.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16878020     DOI: 10.1097/01.shk.0000226266.99960.d0

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  20 in total

1.  Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1.

Authors:  Anna A Birukova; Junjie Xing; Panfeng Fu; Bakhtiyor Yakubov; Oleksii Dubrovskyi; Jennifer A Fortune; Alexander M Klibanov; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-08-20       Impact factor: 5.464

2.  Opposite effects of ANP receptors in attenuation of LPS-induced endothelial permeability and lung injury.

Authors:  Junjie Xing; Bakhtiyor Yakubov; Valeriy Poroyko; Anna A Birukova
Journal:  Microvasc Res       Date:  2011-10-06       Impact factor: 3.514

3.  Dynamic detection of N-terminal pro-B-type natriuretic peptide helps to predict the outcome of patients with major trauma.

Authors:  A Qian; M Zhang; G Zhao
Journal:  Eur J Trauma Emerg Surg       Date:  2014-06-03       Impact factor: 3.693

4.  Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction.

Authors:  Junjie Xing; Nurgul Moldobaeva; Anna A Birukova
Journal:  J Appl Physiol (1985)       Date:  2010-11-04

5.  Role of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide.

Authors:  Yufeng Tian; Isa Mambetsariev; Nicolene Sarich; Fanyong Meng; Anna A Birukova
Journal:  Biochim Biophys Acta       Date:  2014-10-27

6.  B-type natriuretic Peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infants.

Authors:  Joon Sik Kim; Eun Jung Shim
Journal:  Korean Circ J       Date:  2012-03-26       Impact factor: 3.243

7.  Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.

Authors:  Zenggeng Wang; Qinghua Wu; Xiangbi Nie; Jinghua Guo; Chunli Yang
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

Review 8.  Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failure.

Authors:  Jun R Chiong; Geoffrey T Jao; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

Review 9.  Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?

Authors:  Afif El-Khuffash; Eleanor J Molloy
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-07       Impact factor: 5.747

10.  Brain natriuretic peptide and cardiac troponin I for prediction of the prognosis in cancer patients with sepsis.

Authors:  Yong Yang; Jiahua Leng; Xiuyun Tian; Hongzhi Wang; Chunyi Hao
Journal:  BMC Anesthesiol       Date:  2021-05-24       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.